Vaishali Pharma Limited (VAISHALI) - Net Assets

Latest as of March 2026: Rs691.15 Million INR ≈ $7.47 Million USD

Based on the latest financial reports, Vaishali Pharma Limited (VAISHALI) has net assets worth Rs691.15 Million INR (≈ $7.47 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs1.23 Billion ≈ $13.34 Million USD) and total liabilities (Rs542.74 Million ≈ $5.87 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Vaishali Pharma Limited (VAISHALI) strategic asset index to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rs691.15 Million
% of Total Assets	56.01%
Annual Growth Rate	28.07%
5-Year Change	162.26%
10-Year Change	1686.62%
Growth Volatility	112.58

Vaishali Pharma Limited - Net Assets Trend (2013–2026)

This chart illustrates how Vaishali Pharma Limited's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see VAISHALI market cap.

Annual Net Assets for Vaishali Pharma Limited (2013–2026)

The table below shows the annual net assets of Vaishali Pharma Limited from 2013 to 2026. Also explore VAISHALI net asset momentum to track the company's year-over-year net asset growth rate.

Year	Net Assets	Change
2026-03-31	Rs691.15 Million ≈ $7.47 Million	+6.47%
2025-03-31	Rs649.16 Million ≈ $7.02 Million	+51.53%
2024-03-31	Rs428.39 Million ≈ $4.63 Million	+5.69%
2023-03-31	Rs405.31 Million ≈ $4.38 Million	+53.79%
2022-03-31	Rs263.54 Million ≈ $2.85 Million	+17.56%
2021-03-31	Rs224.19 Million ≈ $2.42 Million	+4.85%
2020-03-31	Rs213.81 Million ≈ $2.31 Million	-0.08%
2019-03-31	Rs213.99 Million ≈ $2.31 Million	+3.87%
2018-03-31	Rs206.02 Million ≈ $2.23 Million	+432.55%
2017-03-31	Rs38.69 Million ≈ $418.36K	+18.89%
2016-03-31	Rs32.54 Million ≈ $351.88K	+0.58%
2015-03-31	Rs32.35 Million ≈ $349.85K	+5.25%
2014-03-31	Rs30.74 Million ≈ $332.40K	+10.84%
2013-03-31	Rs27.73 Million ≈ $299.89K	--

Equity Component Analysis

This analysis shows how different components contribute to Vaishali Pharma Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 784.9% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (March 2026)

Component	Amount	Percentage
Retained Earnings	Rs201.13 Million	29.10%
Common Stock	Rs260.92 Million	37.75%
Other Comprehensive Income	Rs430.23 Million	62.25%
Total Equity	Rs691.15 Million	100.00%

Vaishali Pharma Limited Competitors by Market Cap

The table below lists competitors of Vaishali Pharma Limited ranked by their market capitalization.

Company	Market Cap
Cannabist Company Holdings Inc NEO:CBST	$12.41 Million
Gratifii Ltd AU:GTI	$12.42 Million
Gaming Corps AB ST:GCOR	$12.43 Million
Wizz Air Holdings PLC LSE:WIZZ	$12.44 Million
ICH Co Ltd KQ:368600	$12.40 Million
Active Biotech AB ST:ACTI	$12.40 Million
Putprop Ltd JSE:PPR	$12.39 Million
Sri Adhikari Brothers Television Network Limited NSE:SABTNL	$12.39 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Vaishali Pharma Limited's equity between the two most recent reporting periods.

Equity Growth Insights

From 2025 to 2026, total equity changed from 649,161,000 to 691,153,000, a change of 41,992,000 (6.5%).
Net income of 41,648,000 contributed positively to equity growth.
Other comprehensive income increased equity by 428,388,001.
Other factors decreased equity by 428,044,001.

Equity Change Factors (2025 to 2026)

Factor	Impact	Contribution
Net Income	Rs41.65 Million	+6.03%
Other Comprehensive Income	Rs428.39 Million	+61.98%
Other Changes	Rs-428.04 Million	-61.93%
Total Change	Rs-	6.47%

Book Value vs Market Value Analysis

This analysis compares Vaishali Pharma Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 1.66x
The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
The price-to-book ratio has decreased from 3.34x to 1.66x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2013-03-31	Rs2.63	Rs8.79	x
2014-03-31	Rs2.91	Rs8.79	x
2015-03-31	Rs3.07	Rs8.79	x
2016-03-31	Rs3.09	Rs8.79	x
2017-03-31	Rs3.67	Rs8.79	x
2018-03-31	Rs22.76	Rs8.79	x
2019-03-31	Rs20.29	Rs8.79	x
2020-03-31	Rs20.27	Rs8.79	x
2021-03-31	Rs21.26	Rs8.79	x
2022-03-31	Rs24.99	Rs8.79	x
2023-03-31	Rs36.28	Rs8.79	x
2024-03-31	Rs37.21	Rs8.79	x
2025-03-31	Rs44.10	Rs8.79	x
2026-03-31	Rs5.31	Rs8.79	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Vaishali Pharma Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 6.03%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 3.83%
• Asset Turnover: 0.88x
• Equity Multiplier: 1.79x
Recent ROE (6.03%) is below the historical average (7.51%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2013	21.64%	0.51%	2.45x	17.52x	Rs3.23 Million
2014	9.78%	0.25%	2.26x	17.38x	Rs-68.60K
2015	4.99%	0.17%	2.06x	14.16x	Rs-1.62 Million
2016	-0.93%	-0.05%	1.34x	15.30x	Rs-3.56 Million
2017	17.16%	1.00%	1.48x	11.54x	Rs2.77 Million
2018	3.87%	1.22%	1.02x	3.12x	Rs-12.63 Million
2019	3.33%	0.98%	1.05x	3.21x	Rs-14.26 Million
2020	0.15%	0.06%	0.88x	3.10x	Rs-21.05 Million
2021	4.67%	1.95%	0.62x	3.84x	Rs-11.96 Million
2022	15.27%	5.31%	0.93x	3.10x	Rs13.88 Million
2023	16.29%	9.48%	0.88x	1.95x	Rs25.50 Million
2024	1.68%	0.83%	1.08x	1.87x	Rs-35.65 Million
2025	1.26%	0.83%	0.90x	1.69x	Rs-56.74 Million
2026	6.03%	3.83%	0.88x	1.79x	Rs-27.47 Million

Industry Comparison

This section compares Vaishali Pharma Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $55,732,551,119
Average return on equity (ROE) among peers: 12.78%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Vaishali Pharma Limited (VAISHALI)	Rs691.15 Million	21.64%	0.79x	$12.40 Million
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS)	$354.09 Million	3.07%	2.25x	$31.32 Million
Aarti Drugs Limited (AARTIDRUGS)	$1.00 Billion	13.75%	2.66x	$426.21 Million
Aarti Pharmalabs Limited (AARTIPHARM)	$2.31 Million	-8.08%	0.08x	$804.25 Million
Abbott India Limited (ABBOTINDIA)	$36.99 Billion	32.48%	0.40x	$6.27 Billion
Ajanta Pharma Limited (AJANTPHARM)	$29.96 Billion	21.83%	0.26x	$4.81 Billion
Akums Drugs and Pharmaceutical (AKUMS)	$33.31 Billion	7.66%	0.64x	$1.30 Billion
Alkem Laboratories Limited (ALKEM)	$75.58 Billion	20.97%	0.52x	$7.07 Billion
Amrutanjan Health Care Limited (AMRUTANJAN)	$1.29 Billion	15.52%	0.29x	$154.33 Million
Alembic Pharmaceuticals Limited (APLLTD)	$52.38 Billion	9.95%	0.36x	$1.80 Billion
Aurobindo Pharma Limited (AUROPHARMA)	$326.47 Billion	10.68%	0.52x	$10.79 Billion

About Vaishali Pharma Limited

NSE:VAISHALI India Drug Manufacturers - Specialty & Generic

Market Cap

$12.40 Million

Rs1.15 Billion INR

Market Cap Rank

#26589 Global

#1471 in India

Share Price

Rs8.79

Change (1 day)

+0.11%

52-Week Range

Rs4.88 - Rs12.11

All Time High

Rs42.57